Novo Nordisk CEO Mike Doustdar Talks Drug Sales

Bloomberg Talks
05/11/2025 6 min
Novo Nordisk CEO Mike Doustdar Talks Drug Sales

Listen "Novo Nordisk CEO Mike Doustdar Talks Drug Sales "

Descargar episodio Ver en sitio original

Episode Synopsis

Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic. It underscores the challenges facing its new chief executive Mike Doustdar. He spoke to Bloomberg's Guy Johnson about the experience so far.   See omnystudio.com/listener for privacy information.

More episodes of the podcast Bloomberg Talks

FIFA World Cup NYNJ CEO Alex Lasry Talks World Cup 05/12/2025
Hakeem Jeffries Talks Healthcare costs, Redistricting 05/12/2025
Interior Secretary Doug Burgum Talks Energy Plan 05/12/2025
Goldman Sachs Vice Chair Rob Kaplan Talks Next Fed Chair 05/12/2025
Mercedes-AMG Petronas F1 CEO Toto Wolff & PepsiCo's Eugene Willemsen Talk F1 05/12/2025
EU Commission's Roxana Minzatu Talks Future-Proofing ‘Quality Jobs’ 04/12/2025
LendingClub CEO Scott Sanborn Talks Credit & Holiday Spending 03/12/2025
Ford Philanthropy President Mary Culler Talks Ford’s $100 million in Contributions 03/12/2025
NFL Hall of Famer Fran Tarkenton Talks Football & Entrepreneurial Endeavors 03/12/2025
IEA Head Fatih Birol Talks EU’s Russia Gas Phase-Out 03/12/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA